Document:

EXHIBIT 10.14

THE NOTE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"). THIS NOTE MAY NOT BE TRANSFERRED
EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS OR (B) PURSUANT TO AN EXEMPTION FROM SUCH
REGISTRATION UNDER THE ACT AND SUCH STATE SECURITIES LAWS. THIS LEGEND SHALL BE
ENDORSED UPON ANY NOTE ISSUED IN EXCHANGE FOR THIS NOTE.

                              SOMANTA INCORPORATED

           Amended and Restated Secured Convertible Promissory Note

Up to $1,250,000                                                November 8, 2005

         This Amended and Restated Secured Convertible Promissory Note (this
"Note") amends, restates and replaces in its entirety that certain Existing Note
(as hereinafter defined) and is issued in substitution by Somanta Incorporated
(formerly Bridge Oncology Products, Inc.), a Delaware corporation (the
"Company"), with its principal executive office at 19200 Von Karman Avenue,
Suite 400, Irvine, CA 92612, in favor of SCO Capital Partners LLC, a Delaware
limited liability company, with offices at 1285 Avenue of the Americas, 35th
Floor, New York, New York 10019 ("SCO" and together with any permitted
registered assigns, the "Payee"). The "Existing Note" means that certain Secured
Convertible Promissory Note of the Company, $1,000,000 principal amount, issued
in favor of SCO on August 23, 2005.

         FOR VALUE RECEIVED, the Company, promises to pay to the order of Payee
the principal sum equal to the aggregate principal amount of all Tranches loaned
to the Company by Payee (the "Principal Amount"), which Principal Amount shall
in no event exceed $1,250,000, plus all accrued and unpaid interest thereon,
pursuant to the Letter Agreement dated as of even date herewith, between the
Company and the Payee (the "Letter Agreement"), on the Maturity Date.
Capitalized terms used and not defined herein shall have the meanings ascribed
thereto in the Letter Agreement.

         The Initial Tranche in the amount of One Million Dollars ($1,000,000)
was fully funded and delivered by the Payee to the Company on August 23, 2005
and has been accruing interest at the Base Interest Rate (as defined below)
since such date. Subject to the conditions specified herein and in the Letter
Agreement, Additional Tranches will be made available to the Company on or after
the date hereof in such amounts as may be requested by the Company pursuant to a
Request Letter, provided that (i) no such Tranche shall be in a principal amount
less than $50,000, (ii) the aggregate amount of all Tranches hereunder shall not
exceed the Maximum Funded Amount and (iii) the Company shall have delivered to
SCO a duly authorized and executed Warrant together with its initial Request
Letter. Each Additional Tranche will be funded within two (2) business days
following the date on which SCO has received a Request Letter specifying the
<PAGE>

requested amount of such Additional Tranche and a certification (in form and
substance satisfactory to SCO) signed by an authorized officer of the Company
that all applicable conditions to funding set forth herein have been satisfied
and that (i) the Company is not in breach of any covenant provided in this Note,
the Letter Agreement, the Security Documents, the Engagement Letter, the Warrant
or any other agreement between the Company and either SCO or SCO Securities LLC
in connection with the foregoing agreements (collectively, the "Transaction
Documents") and (ii) any and all representations and warranties made by the
Company in this Note shall be true and correct as of the time of funding of each
such Additional Tranche.

         The Company hereby authorizes the Payee to endorse on the Schedule of
Tranches attached to this Note as Exhibit A all Tranches made to the Company and
all payments of principal amounts in respect of such Tranches, which
endorsements shall, in the absence of manifest error, be conclusive as to the
outstanding principal amount of all Tranches; provided, however, that the
failure to make such notation with respect to any Tranche or payment shall not
limit or otherwise affect the obligations of the Company under the Letter
Agreement, this Note or otherwise.

                  The Maturity Date shall mean the earliest of (i) the date on
which any Qualified Financing (as defined herein) occurs, (ii) the date on which
an Event of Default (as defined herein) occurs, or (iii) February 28, 2006;
provided, however, that upon the occurrence of an Event of Default the Payee
shall, at its sole discretion, have the right to defer payment of the amounts
due under this Note until February 28, 2007 and shall maintain its conversion
right pursuant to Section 9 hereof until such date. "Qualified Financing" means
the consummation by the Company (or the parent of the Company, as the case may
be) of its next round of equity financing resulting in gross proceeds to the
Company of at least Five Million Dollars ($5,000,000.00), which amount shall not
include amounts that may be invested through the conversion of this Note or any
other promissory notes issued by the Company, and as to which at least Two
Million, Five Hundred Thousand Dollars ($2,500,000) of such securities issued by
the Company (or the parent of the Company, as the case may be) in such financing
(the "New Securities") are purchased by institutional investors. The Principal
Amount, accrued interest and any other amounts due under this Note are payable
in such coin or currency of the United States of America as at the time of
payment shall be legal tender for the payment of public and private debts.
Interest on this Note shall accrue on the Principal Amount outstanding from time
to time, commencing on the date hereof, at a rate per annum computed in
accordance with Section 4 hereof. This Note is made with full recourse to the
Company and upon all the warranties, representations, covenants and agreements
contained herein. Any amounts borrowed and repaid pursuant to this Note may not
be reborrowed.

         The Company (i) waives presentment, demand, protest or notice of any
kind in connection with this Note and (ii) agrees, upon the occurrence of an
Event of Default (as defined below), to pay to the holder of this Note, on
demand, all reasonable out-of-pocket costs and expenses (including legal fees)
incurred in connection with the enforcement and collection of this Note.

         1.       Prepayment. This Note shall not be subject to any prepayment
by the Company without the consent of the Payee in its sole discretion, except
that the Company may prepay this Note in its entirety, plus all accrued and

                                      -2-
<PAGE>

unpaid interest hereon, within five business days following the consummation by
the Company (or the parent of the Company, as the case may be) of its next round
of equity financing resulting in gross proceeds to the Company of at least Six
Million Dollars ($6,000,000.00), which amount shall not include amounts (i) that
may be invested through the conversion of this Note or any other promissory
notes issued by the Company and (ii) that may be invested by SCO or any other
Bridge Holder (as defined below).

         2.       Day of Payment. Whenever any payment to be made hereunder
shall become due and payable on a day which is not a Business Day (as defined
below), such payment may be made on the next succeeding Business Day without
being deemed past due and, in the case of any payment of principal, such
extension of time shall in such case be included in computing interest on such
payment. As used herein, "Business Day" shall mean any day which is not a
Saturday or Sunday and on which banks in the State of New York are not
authorized or required to close. Interest on past due principal and accrued
interest thereon shall be calculated as follows: the aggregate amount of
principal and interest past due as of such day of determination multiplied by
the Default Interest Rate (as defined herein) and multiplied by a fraction, the
numerator of which is the number of days such aggregate principal and interest
is past due as of such day of determination and the denominator of which is 360.

         3.       Use of Proceeds. The Company shall use the proceeds of each
Tranche solely for the purposes set forth on Schedule A, unless otherwise
consented to in writing by Payee.

         4.       Computation of Interest.

                  A. Base Interest Rate. Subject to subsections 4B and 4C below,
the outstanding Principal Amount shall bear interest at a per annum rate of 7.5%
(the "Base Interest Rate"), payable on the Maturity Date.

                  B. Penalty Interest. In the event the Note is not repaid on
the Maturity Date, the rate of interest applicable to the unpaid Principal
Amount and accrued interest thereon shall be adjusted to twelve percent (12%)
per annum (the "Default Interest Rate") from the date of default until
repayment; provided, that in no event shall the interest rate exceed the Maximum
Rate provided in Section 4C below.

                  C. Maximum Rate. In the event that it is determined that New
York law is not applicable to the indebtedness evidenced by this Note or that
under New York law ("Applicable Usury Laws") the interest, charges and fees
payable by the Company in connection herewith or in connection with any other
document or instrument executed and delivered in connection herewith cause the
effective interest rate applicable to the indebtedness evidenced by this Note to
exceed the maximum rate allowed by law (the "Maximum Rate"), then such interest
shall be recalculated for the period in question and any excess over the Maximum
Rate paid with respect to such period shall be credited, without further
agreement or notice, to the Principal Amount outstanding hereunder to reduce
said balance by such amount with the same force and effect as though the Company
had specifically designated such extra sums to be so applied to principal and
the Payee had agreed to accept such extra payment(s) as a premium-free
prepayment. All such deemed prepayments shall be applied to the principal
balance payable at maturity.

                                      -3-
<PAGE>

         5.       Collateral. This Note is secured by a Security Agreement dated
as of August 22, 2005 (as amended, modified or supplemented from time to time,
the "Security Agreement") of the Company in favor of the Payee covering all
assets and future assets of the Company therein described (collectively, the
"Collateral"), and is entitled to the benefits thereof. The Security Agreement,
the Uniform Commercial Code financing statements in connection with the Security
Agreement, and any and all other documents executed and delivered by the Company
to the Payee under which the Payee is granted liens on assets of the Company are
collectively referred to as the "Security Documents."

         6.       Covenants of Company.

                  A. Affirmative Covenants. The Company covenants and agrees
with respect to the Company and each of its Subsidiaries (which, for purposes of
this Note means any entity (i) in which the Company, directly or indirectly,
owns 51% of the capital stock or holds an equity or similar interest and (ii)
which conducts substantive business activities or holds material assets) that on
and after the date hereof, so long as this Note shall remain in effect, or the
Principal Amount of, or interest thereon, or any fee, expense or amount payable
hereunder or with respect to this Note shall be unpaid, it will perform the
obligations set forth in this Section 6A:

                  (i)      Conduct of Business. The Company will, and will cause
each of its Subsidiaries to, use its best efforts to conduct its business in a
manner consistent with past practices, do or to be done all things necessary to
preserve relationship with its material vendors, customers, distributors, sales
representatives and others having material business relationships with the
Company or any of its Subsidiaries, and obtain the consent of the Payee on any
capital expenditure in excess of $25,000, unless such expenditure is accounted
for on Schedule A hereto. The Company will, and will cause each of its
Subsidiaries to, use commercially reasonable efforts to perform all obligations,
and comply with the terms and provisions of, any Contract (as such term is
defined in the Security Agreement) to which it is a party;

                  (ii)     Taxes and Levies. The Company will, and will cause
each of its Subsidiaries to, promptly pay and discharge all taxes, assessments,
and governmental charges or levies imposed upon the Company or any of its
Subsidiaries, or upon any of their income and profits, or upon any of their
property, before the same shall become delinquent, as well as all claims for
labor, materials and supplies which, if unpaid, might become a lien or charge
upon such properties or any part thereof; provided, however, that neither the
Company nor any of its Subsidiaries shall be required to pay and discharge any
such tax, assessment, charge, levy or claim so long as the validity thereof
shall be contested in good faith by appropriate proceedings and the Company and
each of its Subsidiaries shall set aside on its books adequate reserves in
accordance with generally accepted accounting principles ("GAAP") with respect
to any such tax, assessment, charge, levy or claim so contested; provided,
further, that this Section 6A(ii) shall not apply to those claims for labor,
materials and supplies which the Payee consents in writing shall be excluded
herewith, notwithstanding that such claims, if unpaid, might become a lien or
charge upon such properties or any part thereof.

                  (iii)    Maintenance of Existence. The Company will, and will
cause each of its Subsidiaries to, do or cause to be done all things reasonably
necessary to preserve and keep in full force and effect its corporate existence,
rights (character and statutory) and franchises, except where the failure to

                                      -4-
<PAGE>

comply would not have a Material Adverse Effect (as defined herein) on the
Company or any of its Subsidiaries;

                  (iv)     Maintenance of Property. The Company will, and will
cause each of its Subsidiaries to, at all times maintain, preserve, protect and
keep its property used or useful in the conduct of its business in good repair,
working order and condition, and from time to time make all needful and proper
repairs, renewals, replacements and improvements thereto as shall be reasonably
required in the conduct of its business and protect and maintain its licenses
and its patents, copyrights, trademarks and trade secrets and all registrations
and application for registration thereof except where the failure to take such
action would not reasonably be expected to have a Material Adverse Effect;

                  (v)      Compliance with Laws. The Company will, and will
cause each of its Subsidiaries to, use its best efforts to comply with all
applicable statutes, regulations and orders of, and all applicable restrictions
imposed by, any governmental agency, in respect of the conduct of its business
and the ownership of its properties (including without limitation applicable
statutes, regulations and orders relating to equal employment opportunities or
environmental standards or controls), except such as are being contested in good
faith by appropriate proceedings, except where failure to comply would not have
a Material Adverse Effect;

                  (vi)     Insurance. The Company will, and will cause each of
its Subsidiaries to, keep adequately insured all property of a character usually
insured by similar corporations and carry such other insurance as is usually
carried by similar corporations;

                  (vii)    Books and Records. The Company will, and will cause
each of its Subsidiaries to, at all times keep true and correct books, records
and accounts reflecting all of its business affairs and transactions in
accordance with GAAP. Such books and records shall be open at reasonable times
and upon reasonable notice to the inspection of the Payee or its agents, subject
to customary confidentiality restrictions but in no event more than once in each
month absent a good-faith showing of need for additional inspection;

                  (viii)   Notice of Certain Events. The Company will, and will
cause each of its Subsidiaries to, give prompt written notice (with a
description in reasonable detail) to the Payee of:

                           (a)      the occurrence of any Event of Default or
any event which, with the giving of notice or the lapse of time, would
constitute an Event of Default; and

                           (b)      the delivery of any notice effecting the
acceleration of any indebtedness which singly or together with any other
accelerated indebtedness exceeds $25,000;

                           (c)      the issuance by any court or governmental
agency or authority of any injunction, order, decision or other restraint
prohibiting, or having the effect of prohibiting, the making of or invalidating,
or having the effect of invalidating, any material provision of this Agreement,
of the initiation of any litigation or similar proceedings seeking any such
injunction, order, decision, or other restraint;

                                      -5-
<PAGE>

                           (d)      the filing or commencement of any action,
suit or proceeding against the Company or any of its Subsidiaries, whether at
law or in equity or by or before any court of any Federal, state, municipal or
other governmental agency or authority, which is brought by or on behalf of any
governmental agency or authority, or in which injunctive or other equitable
relief is sought and such relief, if obtained, would materially impair the right
or ability of the Company to perform it obligations under this Note;

                           (e)      the commencement of any claim, litigation,
proceeding or tax audit not covered by insurance when the amount claimed is in
any individual claim, litigation, proceeding or tax audit in excess of $25,000
or, in the aggregate, $50,000; and

                           (f)      of any material development materially and
adversely affecting the business, properties, liabilities, obligations,
financial condition, prospects, operations or results of operations of the
Company and its Subsidiaries, taken as a whole;

                  (ix)     Financial Statements and Information. The Company
shall furnish or cause to be furnished to the Payee:

                           (a)      within 90 days after the end of each fiscal
year, a copy of the audited consolidated balance sheet of the Company and its
Subsidiaries, together with the related statements of income, changes in
stockholder's equity, changes in cash flows as of the end of and for such fiscal
year, all reported on by the accountants to the effect that such consolidated
financial statements present fairly in all material respects the financial
condition and results of operations of the Company and its consolidated
Subsidiaries on a consolidated basis in accordance with GAAP consistently
applied;

                           (b)      within 45 days after the end of each of the
first three fiscal quarters of each fiscal year, a copy of the consolidated
balance sheet of the Company and each of its Subsidiaries together with the
related statements of income and cash flows as of the end of and for such fiscal
quarter and the then elapsed portion of the fiscal year, all certified by one of
its financial officers as presenting fairly in all material respects the
financial conditions and results of operations of the Company and its
consolidated Subsidiaries on a consolidated basis in accordance with GAAP
consistently applied, subject to normal year-end audit adjustments and the
absence of footnotes;

                           (c)      promptly after the same become available,
copies of all proxy statements and other materials distributed by the Company or
any of its Subsidiaries to its stockholders, as the case may be; and

                           (d)      promptly following any request therefor,
such other information regarding the business, financial condition or operations
of the Company or compliance with the terms of this Note, as the Payee may
reasonably request, subject to customary confidentiality agreements and without
causing undue expense to the Company or undue distraction of its employees or
management.

                  B. Negative Covenants. The Company covenants and agrees with
respect to the Company and each of its Subsidiaries that, so long as this Note
shall remain in effect, or the Principal Amount of, or interest thereon, or any
 fee, expense or amount payable hereunder or with respect to this Note shall be
unpaid, it will perform the obligations set forth in this Section 6B:

                                      -6-
<PAGE>

                  (i)      Business in the Ordinary Course. The Company will,
and will cause each of its Subsidiaries to, (i) refrain from engaging in
transactions other than in the ordinary course of business consistent with past
practice; (ii) operate its respective businesses in accordance and in compliance
with all applicable laws, ordinances, rules or regulations or orders, including,
without limitation environmental laws, and all permits, authorizations, consents
and approvals; (iii) maintain all permits and licenses in effect and, if
necessary, make all appropriate filings for the renewal of any permits or
licenses; (iv) refrain from entering into any transaction involving capital
expenditures or commitments therefor (including any borrowings in connection
with such transaction) of more than $25,000, individually, or $50,000 in the
aggregate, or the disposal of any properties or assets (other than inventory in
the ordinary course) with a value of more than $25,000, individually, or
$50,000, in the aggregate, except in the case of foregoing clauses (ii) and
(iii) where the failure to take such action would not reasonably be expected to
have a Material Adverse Effect or where such action is accounted for on Schedule
A hereto;

                  (ii)     Merger, Liquidation, Dissolution. The Company will
not, and will not permit any of its Subsidiaries to, liquidate or dissolve,
consolidate with, or merge into or with, any other corporation or other entity,
except that any wholly-owned subsidiary may merge with another wholly-owned
subsidiary or with the Company (so long as the Company is the surviving
corporation and no Event of Default shall occur as a result thereof); provided,
however, that the Company may permit its Subsidiaries to liquidate or dissolve
only on the condition that all of the assets of such Subsidiaries are
immediately transferred to the Company and only if such liquidation or
dissolution, as the case may be, would not result in a Material Adverse Effect;

                  (iii)    Sales of Assets. The Company will not, and will not
permit any of its Subsidiaries to, sell, transfer, lease or otherwise dispose
of, or grant options, warrants or other rights with respect to, all or a
substantial part of its properties or assets to any person or entity, provided
that this clause (iii) shall not restrict any disposition made in the ordinary
course of business and consisting of capital goods which are obsolete or have no
remaining useful life;

                  (iv)     Acquisition, Transfer or License of Intellectual
Property. The Company will not, and will not permit any of its Subsidiaries to,
acquire, sell, transfer, assign, license (whether as licensee or licensor),
sublicense (whether as sublicensee or sublicensor) or otherwise obtain, dispose
of or encumber any of the Company's or its Subsidiary's Intellectual Property
(as defined below) or any Intellectual Property of any third party, as the case
may be;

                  (v)      Redemptions. The Company will not redeem or
repurchase any outstanding equity and/or debt securities of the Company or its
Subsidiaries (or securities convertible into or exchangeable for equity
securities of such entity);

                  (vi)     Indebtedness. Other than indebtedness for borrowed
money of the Company or any of its Subsidiaries existing on the date of this
Note and identified on the schedule delivered to the Payee on the date hereof,
neither the Company nor any of its Subsidiaries will hereafter create, incur,
assume or suffer to exist, contingently or otherwise, any indebtedness for

                                      -7-
<PAGE>

borrowed money, except (A) in the ordinary course of business (consistent with
past practice) but not to exceed $50,000 in the aggregate at any time
outstanding and (B) the insurance premium financing arrangements with AFCO in
the aggregate amount of $70,578;

                  (vii)    Negative Pledge. Other than Liens (as defined below)
existing on the date of this Note and expressly identified in the schedule
delivered to the Payee on the date hereof, the Company will not, and will not
permit any of its Subsidiaries to, hereafter create, incur, assume or suffer to
exist any mortgage, pledge, hypothecation, assignment, security interest,
encumbrance, lien (statutory or other), preference, priority or other security
agreement or preferential arrangement of any kind or nature whatsoever
(including any conditional sale or other title retention agreement and any
financing lease) (each, a "Lien") upon any of its property, revenues or assets,
whether now owned or hereafter acquired, except:

                           (a)      Liens for taxes, assessments or other
governmental charges or levies not at the time delinquent or thereafter payable
without penalty or being contested in good faith by appropriate proceedings and
for which adequate reserves in accordance with GAAP shall have been set aside on
its books;

                           (b)      Liens of carriers, warehousemen, mechanics,
materialman and landlords incurred in the ordinary course of business for sums
not overdue or being contested in good faith by appropriate proceedings and for
which adequate reserves in accordance with GAAP shall have been set aside on its
books;

                           (c)      Liens (other than Liens arising under the
Employee Retirement Income Security Act of 1974, as amended, or Section 412(n)
of the Internal Revenue Code of 1986, as amended) incurred in the ordinary
course of business in connection with workers' compensation, unemployment
insurance or other forms of governmental insurance or benefits, or to secure
performance of tenders, statutory obligations, leases and contracts (other than
for borrowed money) entered into in the ordinary course of business or to secure
obligations on surety or appeal bonds;

                           (d)      Judgment Liens in existence less than 30
days after the entry thereof or with respect to which execution has been stayed
in an amount not to exceed $25,000 singly or in the aggregate; and

                           (e)      any security interest granted to Immunodex,
Inc. or its successor in the BrE3 and Mc3 cell lines solely in connection with
that certain license agreement dated as of August 18, 2005, between Immunodex,
Inc. and Somanta Limited (the liens described in (a)-(e) being referred to
herein as "Permitted Liens");

                  (viii)   Investments. The Company will not, and will not
permit any of its Subsidiaries to, purchase, own, invest in or otherwise
acquire, directly or indirectly, any stock or other securities or make or permit
to exist any investment or capital contribution or acquire any interest
whatsoever in any other person or entity or permit to exist any loans or
advances for such purposes except for (i) investments in direct obligations of
the United States of America or any agency thereof, (ii) obligations guaranteed
by the United States of America, (iii) certificates of deposit or other
obligations of any bank or trust company organized under the laws of the United

                                      -8-
<PAGE>

States or any state thereof and having capital and surplus of at least $500,000,
(iv) existing investments in Subsidiaries, or (v) an investment in any
subsidiary created for the purpose of making that investment;

                  (ix)     Transactions with Affiliates. The Company will not,
and will not permit any of its Subsidiaries to, enter into any transaction,
including, without limitation, the purchase, sale, lease or exchange of
property, real or personal, the purchase or sale of any security, the borrowing
or lending of any money, or the rendering of any service, with any person or
entity affiliated with the Company or any of its Subsidiaries (including
officers, directors and shareholders owning five (5%) percent or more of the
Company's outstanding capital stock), except (i) in the ordinary course of and
pursuant to the reasonable requirements of its business and upon fair and
reasonable terms not less favorable than would be obtained in a comparable
arms-length transaction with any other person or entity not affiliated with the
Company and, where the transaction is valued in excess of $5,000, with the prior
written consent of the Payee, which shall not be unreasonably withheld, (ii)
transactions pursuant to existing agreements as set forth on Schedule B hereto
delivered to the Payee on the date hereof and (iii) transactions contemplated by
the Transaction Documents and any other agreements entered into in connection
with this Note;

                  (x)      Fundamental Changes. The Company will not, and will
not permit any of its Subsidiaries to, consolidate or merge with any other
person or entity, or to permit any other person or entity to merge into or
consolidate with it or any of its Subsidiaries;

                  (xi)     Acquisitions. The Company will not, and will not
permit any of its Subsidiaries to, at any time, acquire all or substantially all
of the assets or any of the capital stock of any person or entity, except that
the Company may acquire the assets of any of its wholly-owned subsidiaries;

                  (xii)    Restricted Payments. The Company will not, and will
not permit any of its Subsidiaries to, declare, pay or make any dividend or
other distribution, direct or indirect, on account of any shares of capital
stock in such person or entity now or hereafter outstanding (other than a
dividend payable solely in shares of such capital stock to the holders of such
shares) or any redemption, retirement, sinking fund or similar payment, purchase
or other acquisition, direct or indirect, of any shares of any class of its
capital stock now or hereafter outstanding (collectively, "Restricted
Payments"), except:

                           (a)      any wholly-owned subsidiary of the Company
may make Restricted Payments to the Company; and

                           (b)      Restricted Payments made by any Subsidiary
of the Company to the Company in amounts sufficient to enable the Company, as
the consolidated taxpayer for itself and its Subsidiaries, if applicable, to pay
taxes when due;

                  (xiii)   Lines of Business. Except as contemplated by the
agreements entered into in connection with this Note, the Company will not, and
will not permit any of its Subsidiaries to, materially change the nature of the
business of the Company and its Subsidiaries as conducted on the date hereof or

                                      -9-
<PAGE>

enter into any new business which materially increase the risk profile of the
Company and its Subsidiaries, taken as a whole;

                  (xiv)    Amendment of Documents. Other than as may be required
in connection with the consummation of a Qualified Financing, the Company will
not, and will not permit any of its Subsidiaries to, modify, amend, supplement
or terminate, or agree to modify, amend, supplement or terminate, their
organizational documents;

                  (xv)     Stock Option Plan; Board of Directors.
Notwithstanding anything to the contrary set forth in this Note, the Company
will not, and will not permit any of its Subsidiaries to, without the written
consent of the Payee (a) adopt a stock option plan other than the Company's 2005
Omnibus Equity Incentive Plan, pursuant to which eight million (8,000,000)
shares of common stock of the Company have been reserved (the "2005 Plan"), or
increase the number of shares of common stock issuable pursuant to an existing
stock option plan, including, without limitation, the 2005 Plan or (b) amend its
by-laws to increase the number of directors serving on its board of directors;
and

                  (xvi)    Issuance of Equity Securities. The Company will not,
and will not permit any of its Subsidiaries to, authorize or issue, or obligate
itself to issue, any equity security (including any security convertible into or
exercisable for any equity security) other than (A) shares of common stock of
the Company issuable upon exercise of the options issued to Somanta
Optionholders pursuant to the Share Exchange Agreement (as defined in the Letter
Agreement) or to holders of options granted under the 2005 Plan, such exercise
pursuant to the terms of such options as originally issued and (B) shares of
capital stock of any Subsidiary issued to the Company.

                  (xvii)   Compliance with Schedule A. Notwithstanding anything
to the contrary set forth in Section 6A or 6B above, if any act or forbearance
from acting is expressly described and accounted for in the Use of Proceeds set
forth on Schedule A hereto, such act, including, without limitation, any
expenditure or entry into or termination of any agreement or contract, or
forbearance from acting, shall not constitute a breach or default under any of
the covenants set forth in Section 6A or 6B as the case may be nor shall it
constitute an Event of Default hereunder.

         7.       Events of Default.

                  A. The term "Event of Default" shall mean any of the events
set forth in this Section 7A:

                  (i)      Non-Payment of Obligations. The Company shall default
in the payment of the principal or accrued interest of this Note as and when the
same shall become due and payable, whether by acceleration or otherwise.

                  (ii)     Non-Performance of Affirmative Covenants. The Company
shall default in the due observance or performance of any covenant set forth in
(a) clauses (i), (iii), (vi), (viii) and (ix) of Section 6A or (b) clauses (ii),
(iv), (v) and (vii) of Section 6A and such default of any covenant set forth in
clauses (ii), (iv), (v) and (vii) of Section 6A shall continue unremediated for
ten (10) Business Days.

                                      -10-
<PAGE>

                  (iii)    Non-Performance of Negative Covenants. The Company
shall default in the due observance or performance of any covenant set forth in
Section 6B.

                  (iv)     Bankruptcy. The Company (or any of its Subsidiaries)
shall:

                           (a)      apply for, consent to, or acquiesce in, the
appointment of a trustee, receiver, sequestrator or other custodian for the
Company or any of its Subsidiaries, or any of their property, or make a general
assignment for the benefit of creditors; or

                           (b)      in the absence of such application, consent
or acquiesce in the appointment of a trustee, receiver, sequestrator or other
custodian for the Company or any of its Subsidiaries, or for any part of their
property; or

                           (c)      permit or suffer to exist (i) the
commencement of any bankruptcy, reorganization, debt arrangement or other case
or proceeding under any bankruptcy or insolvency law, (ii) any dissolution,
winding up or liquidation proceeding, in respect of the Company or any of its
Subsidiaries, or (iii) the appointment of a trustee, receiver, sequestrator or
other custodian, without causing the same to be dismissed within forty-five (45)
days; and, if such case or proceeding is not commenced by the Company or
converted to a voluntary case, such case or proceeding shall be consented to or
acquiesced in by the Company or any of its Subsidiaries, or shall result in the
entry of an order for relief; or

                           (d)      take any corporate or other action
authorizing, or in furtherance of, any of the foregoing; or

                  (v)      Cross-Default. The Company (or any of its Subsidiary)
shall default in the payment when due of any amount payable under any other
obligation for money borrowed in an amount exceeding Twenty Five Thousand
Dollars ($25,000); or

                  (vi)     Cross-Acceleration. Any indebtedness for borrowed
money of the Company (or any of its Subsidiaries) identified on the schedule
delivered to the Payee on the date hereof in an aggregate principal amount
exceeding Twenty Five Thousand Dollars ($25,000) shall be duly declared to be or
shall become due and payable prior to the stated maturity thereof; or

                  (vii)    Orders, Judgments or Decrees. If any order, judgment,
or decree shall be entered in any proceeding against the Company (or any
Subsidiary) requiring such party to divest itself of a substantial part of its
or his assets, or awarding a money judgment or judgments against any such entity
aggregating more than $25,000, and if, within thirty (30) days after entry
thereof, such order, judgment or decree shall not have been discharged or
execution thereof stayed pending appeal; or if, within thirty (30) days after
the expiration of any such stay, such judgment, order or decree shall not have
been discharged; or

                  (viii)   Invalidity of Note or Security Documents. This Note
or any other Security Document shall for any reason cease to be, or shall be
asserted by the Company not to be, a legal, valid and binding obligation of the
Company, enforceable in accordance with its terms, or the security interest or
Lien purported to be created by any of the Security Documents shall for any
reason cease to be, or be asserted by the Company not to be, a valid, first
priority perfected security interest in any Collateral (except to the extent
otherwise permitted under any of the Security Documents); or

                                      -11-
<PAGE>

                  (ix)     Other Breaches, Defaults. The Company shall default
and/or be in breach of any representation, warranty or covenant made by the
Company to the Payee provided under this Note, any Security Document, the Letter
Agreement, the Engagement Letter or any other agreement between the Company and
either SCO or SCO Securities LLC in connection with the foregoing agreements,
other than with respect to those representations and warranties contained in
Section 8 of this Note and in Section 5 of the Security Agreement.

                  B. Rights and Remedies Cumulative. No right or remedy herein
conferred upon the Payee is intended to be exclusive of any other right or
remedy contained herein or in any instrument or document delivered in connection
with or pursuant to this Note or the Security Documents, and every such right or
remedy shall be cumulative and shall be in addition to every other such right or
remedy contained herein and therein or now or hereafter existing at law or in
equity or by statute, or otherwise.

                  C. Rights and Remedies Not Waived. No course of dealing
between the Company and the Payee or any failure or delay on the part of the
Payee in exercising any rights or remedies of the Payee and no single or partial
exercise of any rights or remedies hereunder or under the Security Documents
shall operate as a waiver or preclude the exercise of any other rights or
remedies hereunder.

         8.       Representations of the Company. The Company represents and
warrants to the Payee that:

                  A. Corporate Organization; Etc. The Company and its
Subsidiaries are corporations duly organized, validly existing and in good
standing under the laws of the jurisdiction in which they are incorporated, and
have the full corporate power and authority to carry on their businesses as they
are now being conducted and to own the properties and assets they now own; are
duly qualified or licensed to do business as a foreign corporation in good
standing in the jurisdictions in which such qualification is required, except
where the failure to so qualify or to be so licensed would not have a Material
Adverse Effect on its business, financial condition, results of operations or on
its ability to continue to conduct its business as currently conducted. The
copies of the articles of incorporation and by-laws (or other relevant
organization documents) and any amendments thereto of the Company and each of
its Subsidiaries heretofore delivered to the Payee are complete and correct
copies of such instruments as currently in effect. As used in this Note,
"Material Adverse Effect" means any material adverse effect on the business,
properties, assets, operations, results of operations, prospects or financial
condition of the Company and its Subsidiaries, taken as a whole. The term
"Material Adverse Effect" does not include any material developments adversely
affecting (i) the industry in which the Company is engaged generally or (ii) the
national economy, security, stability or peace of the United States or any
country, taken as a whole.

                  B. Capitalization. The authorized, issued and outstanding
capital stock of the Company prior to the consummation of the transactions
contemplated hereby is set forth in Schedule 8B. All of such outstanding shares
have been and are, or upon issuance will be, validly issued, fully paid and

                                      -12-
<PAGE>

non-assessable. Except as disclosed in the schedule delivered to the Payee on
the date hereof, (i) no shares of the Company's capital stock are subject to
preemptive rights under Delaware law or any other similar rights or any liens or
encumbrances suffered or permitted by the Company; (ii) there are no outstanding
debt securities issued by the Company (other than as may be issued pursuant to
the Letter Agreement); (iii) there are no outstanding options, warrants, scrip,
rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, any shares of capital
stock of the Company or any of its Subsidiaries, or contracts, commitments,
understandings or arrangements by which the Company or any of its Subsidiaries
is or may become bound to issue additional shares of capital stock of the
Company or any of its Subsidiaries or options, warrants, scrip, rights to
subscribe to, calls or commitments of any character whatsoever relating to, or
securities or rights convertible into, any shares of capital stock of the
Company or any of its Subsidiaries; (iv) there are no agreements or arrangements
under which the Company or any of its Subsidiaries is obligated to register the
sale of any of their securities under the 1933 Act; (v) there are no outstanding
securities of the Company or any of its Subsidiaries which contain any
redemption or similar provisions, and there are no contracts, commitments,
understandings or arrangements by which the Company or any of its Subsidiaries
is or may become bound to redeem a security of the Company or any of its
Subsidiaries; (vi) there are no securities or instruments containing
anti-dilution or similar provisions that will be triggered by the issuance of
this Note; and (vii) the Company does not have any stock appreciation rights or
"phantom stock" plans or agreements or any similar plan or agreement. All prior
sales of securities of the Company or any of its Subsidiaries were either
registered under the 1933 Act and applicable state securities laws or exempt
from such registration, and no security holder has any rescission rights with
respect thereto except to the extent any such rights would not reasonably be
expected to have a Material Adverse Effect.

                  C. Financial Statements. The financial statements of the
Company provided to the Payee have been prepared in accordance with GAAP, during
the periods involved (except (i) as may be otherwise indicated in such financial
statements or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may exclude footnotes or may be condensed or
summary statements), show all material liabilities, absolute or contingent, of
the Company required to be required to be recorded thereon, and fairly present
in all material respects the financial position of the Company as of the dates
thereof and the results of its operations and cash flows for the periods
indicated (subject, in the case of unaudited statements, to normal year-end
audit adjustments).

                  D. Absence of Changes. Since April 30, 2005, there have been
no material adverse changes in the financial condition, business or properties
of the Company or of the Company and its Subsidiaries, taken as a whole. Except
as set forth in the schedule to be delivered to the Payee on the date hereof,
since April 30, 2005, (i) the Company has not incurred any liabilities or
obligations, direct or contingent, not in the ordinary course of business, or
entered into any transaction not in the ordinary course of business, which is
material to the business of the Company, (ii) there has not been any change in
the capital stock of, or any incurrence of long-term debt by, the Company, or
any issuance of options, warrants or other rights to purchase the capital stock
of the Company, or any adverse change or any development involving, so far as
the Company can now reasonably foresee, a prospective adverse change in the
condition (financial or otherwise), net worth, results of operations, business,
key personnel or properties which would be material to the business or financial

                                      -13-
<PAGE>

condition of the Company, and (iii) the Company has not become a party to, and
neither the business nor the property of the Company has become the subject of,
any material litigation whether or not in the ordinary course of business.

                  E. Title. Except as set forth in or contemplated by the
schedule to be delivered to the Payee on the date hereof, the Company has good
and marketable title to all material properties and assets owned by it, free and
clear of all liens, charges, encumbrances or restrictions, except as not
prohibited by Section 6(B)(vii) hereof or such as are not significant or
important in relation to the Company's business; all of the material leases and
subleases under which the Company is the lessor or sublessor of properties or
assets or under which the Company holds properties or assets as lessee or
sublessee are in full force and effect, and the Company is not in default in any
material respect with respect to any of the terms or provisions of any of such
leases or subleases, and no material claim has been asserted by anyone adverse
to rights of the Company as lessor, sublessor, lessee or sublessee under any of
the leases or subleases mentioned above, or affecting or questioning the right
of the Company to continued possession of the leased or subleased premises or
assets under any such lease or sublease. The Company owns, leases or licenses
all such properties as are necessary to its operations.

                  F. Intellectual Property Rights. The Company and its
Subsidiaries own or possess adequate rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, patents,
patent rights, copyrights, inventions, licenses, approvals, governmental
authorizations, trade secrets and rights (the "Intellectual Property") necessary
to conduct their respective businesses as now conducted. Except as set forth on
the schedule delivered to the Payee on the date hereof, none of the Company's
Intellectual Property has expired or terminated, or is expected to expire or
terminate within two years from the date of this Note, except where such
expiration or termination would not have either individually or in the aggregate
a Material Adverse Effect. The Company and its Subsidiaries do not have any
knowledge of any infringement by the Company or its Subsidiaries of Intellectual
Property of others, or of any such development of similar or identical trade
secrets or technical information by others and, except as set forth on such
schedule, no claim, action or proceeding has been made or brought against, or to
the Company's knowledge, has been threatened against, the Company or its
Subsidiaries regarding Intellectual Property or other infringement, except where
such infringement, claim, action or proceeding would not reasonably be expected
to have either individually or in the aggregate a Material Adverse Effect.
Except as set forth on such schedule, the Company and its Subsidiaries are
unaware of any facts or circumstances which might give rise to any of the
foregoing. The Company and its Subsidiaries have taken reasonable security
measures to protect the secrecy, confidentiality and value of all of their
Intellectual Property except where the failure to do so would not reasonably be
expected to have either individually or in the aggregate a Material Adverse
Effect.

                  G. Litigation. Except as set forth in or contemplated by the
schedule delivered to the Payee on the date hereof, there is no material action,
suit, investigation, customer complaint, claim or proceeding at law or in equity
by or before any court, arbitrator, governmental instrumentality or authority or
other agency now pending or, to the knowledge of the Company, threatened against
the Company, the adverse outcome of which would be reasonably likely to have a
Material Adverse Effect. The Company is not subject to any judgment, order,
writ, injunction or decree of any Federal, state, municipal or other

                                      -14-
<PAGE>

governmental department, commission, board, bureau, agency or instrumentality,
domestic or foreign which have a Material Adverse Effect.

                  H. Taxes. Except as set forth in or contemplated by the
schedule delivered to the Payee on the date hereof, the Company has filed all
Federal, state, local and foreign tax returns which are required to be filed by
it or otherwise met its disclosure obligations to the relevant agencies and all
such returns are true and correct in all material respects. The Company has paid
or adequately provided for all tax liabilities of the Company as reflected on
such returns or determined to be due on such returns or pursuant to any
assessments received by it or which it is obligated to withhold from amounts
owing to any employee, creditor or third party. There are no unpaid taxes in any
material amount claimed to be due by the taxing authority of any jurisdiction,
and the officers of the Company know of no basis for any such claim. The Company
has properly accrued all taxes required to be accrued by GAAP consistently
applied. The tax returns of the Company have never been audited by any state or
Federal authorities. The Company has not waived any statute of limitations with
respect to taxes or agreed to any extension of time with respect to any tax
assessment or deficiency.

                  I. Compliance With Laws; Licenses; Etc. The business of the
Company and its Subsidiaries is not being conducted in violation of any law,
ordinance or regulation of any governmental entity except for such violations
the sanctions for which either individually or in the aggregate would not
reasonably be expected to have a Material Adverse Effect, and the Company has
not received notice of any violation of or noncompliance with any Federal,
state, local or foreign, laws, ordinances, regulations and orders applicable to
its business which has not been cured, the violation of, or noncompliance with
which, would be reasonably likely to have a Material Adverse Effect. The Company
has all material licenses and permits and other governmental certificates,
authorizations and permits and approvals (collectively, "Licenses") required by
every Federal, state and local government or regulatory body for the operation
of its business as currently conducted and the use of its properties, except
where the failure to be licensed or possess a permit would not reasonably be
expected to have a Material Adverse Effect. The Licenses are in full force and
effect and to the Company's knowledge no violations currently exist in respect
of any License and no proceeding is pending or threatened to revoke or limit any
thereof.

                  J. Existing Indebtedness. The schedule delivered to the Payee
on the date hereof is a complete and correct list of all indebtedness for
borrowed money of the Company and its Subsidiaries in an unpaid principal amount
exceeding $10,000, showing as to each item of such indebtedness the obligor, the
aggregate principal amount outstanding and a brief description of any security
therefor (after giving effect to the application of the proceeds of the sale of
this Note). The Company is not in default in any material respect in the
performance or observance of any of the terms, covenants or conditions contained
in any instrument evidencing any such indebtedness and no event has occurred and
is continuing which, with notice or the lapse of time or both, would become such
a default.

                  K. Security Interest. Assuming that the Security Documents are
in proper form and are perfected in accordance with applicable laws and
regulations on the date thereof, the Security Documents create and grant to the
Payee a legal, valid and perfected first priority security interest in the

                                      -15-
<PAGE>

Collateral. The Collateral is not subject to any other Lien or security interest
whatsoever except Permitted Liens.

                  L. Subsidiaries. As of the date hereof, (i) the Company has
only the Subsidiaries set forth on, and the authorized, issued and outstanding
capital stock of each Subsidiary is as set forth on, the schedule delivered to
the Payee on the date hereof and (ii) the ownership interests in each Subsidiary
of the Company are duly authorized, validly issued, fully paid and nonassessable
and are owned beneficially and of record by the persons set forth on such
schedule, free and clear of all Liens. As of the date hereof, the Subsidiaries
of the Company have not issued any securities convertible into, or options or
warrants for, any common or preferred equity securities thereof, except as set
forth on such schedule. Except as set forth on such schedule, there are no
agreements, voting trusts or understandings binding on the Company or any of its
Subsidiaries restricting the transfer of the voting securities of any of the
Company's Subsidiaries or affecting in any manner the sale, pledge, assignment
or other dispositions thereof, including any right of first refusal, option,
redemption, call or other right with respect thereto, whether similar or
dissimilar to any of the foregoing.

                  M. Investment Companies and Other Regulated Entities. Neither
the Company nor any of its Subsidiaries is (i) an "investment company" or a
company "controlled" by an "investment company" as defined in, or subject to
regulation under, the Investment Company Act of 1940, as amended, or (ii) a
"holding company" as defined in, or subject to regulation under, the Public
Utility Holding Company Act of 1935 or the Federal Power Act, as amended.

                  N. Absence of Certain Restrictions. No indenture, certificate
of designation for preferred stock, agreement or instrument to which the Company
or any of its Subsidiary is a party (other than this Note or any Note issued
pursuant to the Letter Agreement), prohibits or limits in any way, directly or
indirectly the ability of any such Subsidiary to make Restricted Payments or
repay any indebtedness to the Company or to another Subsidiary of the Company.

                  O. Authorization; No Violation.
                     ---------------------------

                  (a)      The Company has full corporate power and authority
necessary to enter into the Transaction Documents to carry out the transactions
contemplated by the Transaction Documents. The Board of Directors of the Company
has taken such necessary action to authorize the execution and delivery of the
Transaction Documents and the consummation of the transactions contemplated
thereby. The Transaction Documents have been duly executed and delivered by the
Company and are legal, valid and binding obligations of the Company enforceable
against it in accordance with its terms except that (i) such enforcement may be
subject to bankruptcy, insolvency, reorganization, moratorium or other similar
laws now or hereafter in effect relating to creditors' rights and (ii) the
remedy of specific performance and injunctive and other forms of equitable
relief may be subject to equitable defenses and to the discretion of the court
before which any proceeding therefore may be brought.

                                      -16-
<PAGE>

                  (b)      Neither the execution and delivery of any of the
Transaction Documents nor the consummation of the transactions contemplated
thereby will violate any provision of the articles or certificate of
incorporation or by-laws or other organizational documents of the Company, be in
conflict with, or constitute a default (or an event which, with notice or lapse
of time or both, would constitute a default) under or result in the termination
of, or accelerate the performance required by, or cause the acceleration of the
maturity of any debt or obligation pursuant to, or result in the creation or
imposition of any security interest, lien or other encumbrance upon any property
or assets of the Company, any agreement or commitment to which the Company is a
party or by which the Company is bound or to which the property of the Company
is subject, or violate any statute or law or any judgment, decree, order,
regulation or rule of any court or governmental authority applicable to the
Company.

         9.       Conversion Right.

                  A. Conversion Upon a Qualified Financing.
                     -------------------------------------

                  (i)      Upon written notice to the Company, the Payee may, at
its sole option, upon the initial closing of the next Qualified Financing,
convert the outstanding principal hereunder and all interest accrued thereon
into such number of shares of fully paid and non-assessable New Securities that
is equal to the quotient of (A) the outstanding principal hereunder plus all
interest accrued thereon divided by (B) the lowest price per share at which New
Securities are issued in the Qualified Financing. In addition, in connection
with such conversion, the Payee shall receive rights as a purchaser and holder
of New Securities (including, without limitation, customary registration rights)
no less favorable in the aggregate and in any single instance than those granted
to any other purchaser of New Securities. The Company agrees that it has no
right to prevent the Payee from effecting such conversion without the Payee's
consent, whether by attempting to prepay this Note (whether or not there shall
have been a default hereunder) or otherwise. For avoidance of doubt, if the
Payee does not elect to convert this Note into New Securities in the Qualified
Financing, then this Note shall become immediately due and payable upon the
consummation of the Qualified Financing, and the Company shall immediately, upon
such consummation, pay in full all outstanding principal hereunder and all
interest accrued thereon to the Payee.

                  (ii)     Notice of Qualified Financing. The Company shall
notify the Payee in writing not less than 10 business days prior to the expected
closing date of any Qualified Financing. Such notice shall include all of the
material terms of the proposed Qualified Financing and shall include, as
promptly as such documents are available, then-current drafts of the transaction
documents for the Qualified Financing. Following such notice, the Company shall
provide Payee with any transaction documents or revised drafts thereof at the
same time that such transaction documents or drafts are made available to any
investor in the Qualified Financing. The Company shall negotiate the terms of
such transaction documents in good faith with the Payee.

                  (iii)    Fractional Shares. Upon the conversion of this Note
pursuant to this Section 9.A, fractional shares representing New Securities
shall be issued only if fractional shares are issuable in connection with the
Qualified Financing to investors generally. If no fractional shares are so
issuable, then with respect to any fraction of a share called for upon the
conversion of this Note or any portion hereof, a cash amount equal to such
fraction shall be paid to the Payee.

                  B. Optional Conversion.
                     -------------------

                                      -17-
<PAGE>

                  (i)      At any time after February 28, 2006, the outstanding
principal hereunder plus all interest accrued thereon may, at the Payee's
option, be converted into such number of shares of common stock, par value $0.01
per share, of the Company (the "Common Stock") that would result in SCO,
together with the other Bridge Holders (as defined below), holding 80% of the
Common Stock of the Company (or of all capital stock of the Company, if
applicable) on and subject to the terms and conditions set forth in this Section
9.B (such number of shares, the "Conversion Number"). For purposes of the
foregoing calculations, the total number of shares of Common Stock (or other
capital stock of the Company, if applicable) shall be determined on a
fully-diluted basis. "Bridge Holders" shall have the meaning assigned to such
term in that certain Voting Agreement dated as of August 22, 2005 (the "Voting
Agreement"), by and among the Company, the persons and entities listed in
Exhibit A thereto as Bridge Holders and the persons and entities listed in
Exhibit B thereto as Somanta Holders, in each case, identified therein.

                  (ii)     Mechanics of Conversion.
                           -----------------------

                           (a)      Such right of conversion shall be exercised
by the Payee by delivering to the Company a conversion notice substantially in
the form attached hereto as Exhibit B (the "Conversion Notice"), appropriately
completed and duly signed, and by surrender not later than five (5) business
days thereafter of this Note (or if the original Note has been lost or
destroyed, an affidavit of Payee in customary form certifying as to such loss or
destruction). The Conversion Notice shall also contain a statement of the name
or names (with addresses and tax identification or social security numbers) in
which the certificate or certificates representing the shares of Common Stock
shall be issued, if other than the name in which this Note is registered.
Promptly after the receipt of the Conversion Notice, the Company shall issue and
deliver, or cause to be delivered, to the Payee or such Payee's nominee, a
certificate or certificates for the number of shares of Common Stock equal to
the Conversion Number which shares shall be fully paid and non-assessable. Such
conversion shall be deemed to have been effected as of the date of receipt by
the Company of the Conversion Notice (the "Conversion Date"), and the person or
persons entitled to receive the shares of Common Stock issuable upon conversion
shall be treated for all purposes as the holder or holders of record of such
shares of Common Stock as of the close of business on the Conversion Date.

                           (b)      The Company shall effect such issuance of
Common Stock within three (3) trading days after the Conversion Date and shall
transmit the certificates by messenger or reputable overnight delivery service
to reach the address designated by the Payee within three (3) trading days after
the receipt by the Company of such Conversion Notice. If certificates evidencing
the Common Stock are not received by the holder within five (5) Business Days
after the Conversion Notice, then the Payee will be entitled to revoke and
withdraw its Conversion Notice, in whole or in part, at any time prior to its
receipt of those certificates. The person or persons entitled to receive the
Common Stock issuable upon such conversion shall be treated for all purposes as
the record holder or holders of such Common Stock on the Conversion Date. If the
conversion has not been rescinded in accordance with this paragraph and the
Company fails to deliver to the holder such certificate or certificates pursuant
to this Section 9B in accordance herewith, prior to the seventh (7th) Business
Day after the Conversion Date (assuming timely surrender of the Note), the
Company shall pay to the Payee, in cash, on a per diem basis, an amount equal to
2% of the principal amount and all interest accrued thereon of the Note until

                                      -18-
<PAGE>

such delivery takes place and interest shall continue to accrue as provided in
Section 4.A as if no Conversion Notice had been delivered.

                  (iii)    The Company's obligation to issue Common Stock upon
conversion of Note shall be absolute, is independent of any covenant of the
Payee, and shall not be subject to: (i) any offset or defense; or (ii) any
claims against the Payee whether pursuant to this Note any Transaction Document
or otherwise.

                  (iv)     Reservation of Shares. The Company shall at all times
reserve and keep available for issuance to the Payee from its authorized but
unissued shares of Common Stock, a number of shares of Common Stock that is
sufficient to fully convert this Note pursuant to this Section 9.B.

                  (v)      Fractional Shares. No fractional shares of Common
Stock shall be issued upon the conversion of this Note pursuant to this Section
9.B. Any fractional share of Common Stock that would otherwise be issuable upon
conversion pursuant to this Section 9.B shall be rounded up to the nearest whole
number of shares of Common Stock.

         10.      Miscellaneous.

                  A. Parties in Interest. All covenants, agreements and
undertakings in this Note binding upon the Company or the Payee shall bind and
inure to the benefit of the successors and permitted assigns of the Company and
the Payee, respectively. The Payee shall not be entitled to assign this Note
without the written consent of the Company, which consent shall not be
unreasonably withheld.

                  B. Governing Law. This Note shall be governed by and construed
in accordance with the laws of the State of New York without regard to the
conflicts of laws or principles thereof. The parties hereto hereby agree that
any suit or proceeding arising directly and/or indirectly pursuant to or under
this instrument or the consummation of the transactions contemplated hereby,
shall be brought solely in a federal or state court located in the City, County
and State of New York. By its execution hereof, the parties hereby covenant and
irrevocably submit to the in personam jurisdiction of the federal and state
courts located in the City, County and State of New York and agree that any
process in any such action may be served upon any of them personally, or by
certified mail or registered mail upon them or their agent, return receipt
requested, with the same full force and effect as if personally served upon them
in New York City. The parties hereto waive any claim that any such jurisdiction
is not a convenient forum for any such suit or proceeding and any defense or
lack of in personam jurisdiction with respect thereto. In the event of any such
action or proceeding, the party prevailing therein shall be entitled to payment
from the other party hereto of its reasonable counsel fees and disbursements in
an amount judicially determined.

                  C. Waiver of Jury Trial. THE PAYEE AND THE COMPANY HEREBY
KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE ANY RIGHTS THEY MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF,
UNDER, OR IN CONNECTION WITH THIS NOTE OR ANY OTHER DOCUMENT OR INSTRUMENT
EXECUTED AND DELIVERED IN CONNECTION HEREWITH OR ANY COURSE OF CONDUCT, COURSE

                                      -19-
<PAGE>

OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF THE PAYEE OR
THE COMPANY. THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE PAYEE'S PURCHASING
THIS NOTE.

                  D. Expenses and Fees. All fees, costs and expenses of every
kind and nature, including but not limited to the reasonable attorneys' fees and
legal expenses, incurred by Payee in connection with the collection,
administration, or enforcement of its rights under this Note or in defending or
prosecuting any actions or proceedings arising out of or related to any amounts
due to Payee under this Note shall be borne and paid by the Company upon written
demand by the Payee and until paid, shall be added to the amounts due hereunder
and bear interest at a rate per annum equal to 12%.

                  E. Entire Agreement. This Note (including any schedule
referenced herein), the Security Documents and the Letter Agreement set forth
the entire agreement of the parties with respect to the subject matter hereof
and thereof, superseding and replacing any agreement or understanding that may
have existed between the parties prior to the date hereof in respect to such
subject matter.

                            [Signature Page Follows.]

                                      -20-
<PAGE>

         IN WITNESS WHEREOF, this Note has been executed and delivered on the
date first specified above by the duly authorized representative of the Company.

                                       SOMANTA INCORPORATED

                                       By: /s/ TERRANCE J. BRUGGEMAN
                                           -------------------------------------
                                           Name:  Terrance J. Bruggeman
                                           Title: Executive Chairman
<PAGE>

                                   Schedule A
                                   ----------

                                 Use of Proceeds
                                 ---------------

<PAGE>

                                   Schedule B
                                   ----------

                             Affiliate Transactions
                             ----------------------

<PAGE>

                                    EXHIBIT A

                              SCHEDULE OF TRANCHES
                              --------------------

--------------------------------------------------------------------------------
      Date         Principal Amount     Unpaid Principal       Name of Person
                     of Tranche         Balance of Note       Making  Notation
--------------------------------------------------------------------------------
August 23, 2005       $1,000,000          $1,000,000
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

<PAGE>

                                    EXHIBIT B

                            FORM OF CONVERSION NOTICE

           (To be executed by the Payee in order to convert the Note)

The undersigned hereby irrevocably elects to convert the Secured Convertible
Promissory Note (the "Note") of Somanta Incorporated, a Delaware corporation
(the "Company"), held by the undersigned into shares of Common Stock, according
to the terms and conditions of the Note and the conditions hereof, as of the
date written below. The undersigned hereby requests that certificates for the
shares of Common Stock to be issued to the undersigned pursuant to this
Conversion Notice be issued in the name of, and delivered to, the undersigned or
its designee as indicated below. If the shares of Common Stock are to be issued
in the name of a person other than the undersigned, the undersigned will pay all
transfer taxes payable with respect thereto. A copy of the Note being converted
is attached hereto (and the original Note shall be transmitted to the
Corporation pursuant to the terms thereof). All capitalized terms used in this
Conversion Notice, but not otherwise defined herein shall have the meanings
assigned in the Note. Execution and delivery of this Conversion Notice by
facsimile shall be valid an binding for all purposes and shall be effective upon
such facsimile transmission.

______________________________________________________________________________
Date of Conversion (Date of Notice)

Conversion Information:[NAME OF PAYEE]

___________________________________

Address of Payee:
___________________________________

___________________________________
Issue Common Stock to (if different than above):
Name:______________________________

Address:___________________________

___________________________________

Tax ID #:__________________________

________________________________________________
Name of Payee

By:_____________________________________________
Name:
Title:EXHIBIT 10.15

                               SECURITY AGREEMENT

         THIS SECURITY AGREEMENT (this "Agreement") is dated as of August 24,
2005, by BRIDGE ONCOLOGY PRODUCTS, INC., a Delaware corporation (the "Grantor"),
in favor of SCO CAPITAL PARTNERS LLC, a Delaware limited liability company (the
"Lender").

                                    Recitals

         WHEREAS, pursuant to that certain letter agreement (the "Letter
Agreement") of even date herewith between the Grantor and Lender, Lender has
made available a secured loan in the principal amount of One Million Dollars
($1,000,000);

         WHEREAS, pursuant to that certain secured convertible promissory note
of even date herewith, issued by the Grantor in favor of the Lender (as the same
may from time to time be amended, modified, supplemented or restated, the
"Note"), Grantor has promised to pay the Obligations (as defined herein) to the
Lender; and

         WHEREAS, the obligations of the Lender under the Letter Agreement are
subject to the condition, among others, that Grantor shall have executed and
delivered to Lender this Agreement.

         NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged by Grantor, Grantor hereby
represents, covenants and agrees with Lender as follows:

1.       Definitions.

         a.       When used in this Agreement the following terms shall have the
                  following meanings (such meanings being equally applicable to
                  both the singular and plural forms of the terms defined):

         "Collateral" has the meaning assigned to such term in Section 2 of this
         Agreement.

         "Contracts" means all contracts (including any customer, vendor,
         supplier, service or maintenance contract), leases, licenses,
         undertakings, purchase orders, permits, franchise agreements or other
         agreements (other than any right evidenced by Chattel Paper, Documents
         or Instruments), whether in written or electronic form, in or under
         which Grantor now holds or hereafter acquires any right, title or
         interest, including, without limitation, with respect to an Account,
         any agreement relating to the terms of payment or the terms of
         performance thereof.

         "Copyrights" means all of the following now owned or hereafter acquired
         or created (as a work for hire for the benefit of Grantor) by Grantor
         or in which Grantor now holds or hereafter acquires or receives any
         right or interest, in whole or in part: (a) all copyrights, whether
         registered or unregistered, held pursuant to the laws of the United
         States, any State thereof or any other country; (b) registrations,
         applications, recordings and proceedings in the United States Copyright
<PAGE>

         Office or in any similar office or agency of the United States, any
         State thereof or any other country; (c) any continuations, renewals or
         extensions thereof; (d) any registrations to be issued in any pending
         applications, and shall include any right or interest in and to work
         protectable by any of the foregoing which are presently or in the
         future owned, created or authorized (as a work for hire for the benefit
         of Grantor) or acquired by Grantor, in whole or in part; (e) prior
         versions of works covered by copyright and all works based upon,
         derived from or incorporating such works; (f) income, royalties,
         damages, claims and payments now and hereafter due and/or payable with
         respect to copyrights, including, without limitation, damages, claims
         and recoveries for past, present or future infringement; (g) rights to
         sue for past, present and future infringements of any copyright; and
         (h) any other rights corresponding to any of the foregoing rights
         throughout the world.

         "Obligations" has the meaning set forth in Section 3 of this Agreement.

         "Patents" means all of the following in which Grantor now holds or
         hereafter acquires any interest: (a) all letters patent of the United
         States or any other country, all registrations and recordings thereof
         and all applications for letters patent of the United States or any
         other country, including, without limitation, registrations, recordings
         and applications in the United States Patent and Trademark Office or in
         any similar office or agency of the United States, any State thereof or
         any other country; (b) all reissues, divisions, continuations,
         renewals, continuations-in-part or extensions thereof; (c) all petty
         patents, divisionals and patents of addition; (d) all patents to issue
         in any such applications; (e) income, royalties, damages, claims and
         payments now and hereafter due and/or payable with respect to patents,
         including, without limitation, damages, claims and recoveries for past,
         present or future infringement; and (f) rights to sue for past, present
         and future infringements of any patent.

         "Trademark" means any of the following in which Grantor now holds or
         hereafter acquires any interest: (a) all trademarks, whether registered
         or unregistered, held pursuant to the laws of the United States, and
         State thereof, or any country (b) registrations, applications,
         recordings and proceedings in the United States Patent and Trademark
         Office or in any similar office or agency of the United States, any
         State thereof or any other country; (c) any continuations, renewals or
         extensions thereof; (d) any registrations to be issued in any pending
         applications (e) income, royalties, damages, claims and payments now
         and hereafter due and/or payable with respect to trademarks, including,
         without limitation, damages, claims and recoveries for past, present or
         future infringement; (g) rights to sue for past, present and future
         infringements of any trademark; and (h) any other rights corresponding
         to any of the foregoing rights throughout the world.

         "UCC" means the Uniform Commercial Code as the same may from time to
         time be in effect in the State of New York; provided, however, in the
         event that, by reason of mandatory provisions of law, any or all of the
         attachment, perfection or priority of Lender's security interest in any
         Collateral is governed by the Uniform Commercial Code as in effect in a
         jurisdiction other than the State of New York, the term "UCC" shall
         mean the Uniform Commercial Code (including the Articles thereof) as in
         effect at such time in such other jurisdiction for purposes of the

                                       2
<PAGE>

         provisions hereof relating to such attachment, perfection or priority
         and for purposes of definitions related to such provisions. In
         addition, the following terms shall have the meanings set forth for
         such terms in the UCC: "Account," "Account Debtor," "Chattel Paper"
         (including tangible and electronic chattel paper), "Commercial Tort
         Claims," "Commodity Account," "Deposit Account," "Documents,"
         "Equipment," "Financial Assets", "Fixtures," "Fixture Filing," "General
         Intangible" (including, without limitation, Payment Intangibles,
         Copyrights, Patents, Trademarks, designs, drawings, technical
         information, marketing plans, customer lists, trade secrets,
         proprietary or confidential information, inventions (whether or not
         patentable), procedures, know-how, models and data), "Instrument,"
         "Intellectual Property," "Inventory" (including all goods held for sale
         or lease or to be furnished under a contract of service, and including
         returns and repossessions), "Investment Property" (including Financial
         Assets, Securities, Securities Accounts and Securities entitlements),
         "Letter-of-Credit Right" (whether or not the letter of credit is
         evidenced by a writing), "Payment Intangibles," "Proceeds," "Promissory
         Notes," "Securities," "Securities Account," "Securities Entitlement"
         and "Supporting Obligations." Each of the foregoing terms shall include
         all of such items now owned, or hereafter acquired, by Grantor.

         b.       Except as otherwise defined herein, all capitalized terms used
                  in this Agreement have the respective meanings given thereto
                  in the Note.

2.       Grant of Security. As collateral security for the full, prompt,
         complete and final payment and performance when due (whether at stated
         maturity, by acceleration or otherwise) of all the Obligations, Grantor
         hereby grants to Lender a lien on and security interest in, all of
         Grantor's right, title and interest in, to and under the following,
         whether now owned or hereafter acquired (all of which being
         collectively referred to herein as the "Collateral"); provided that the
         Collateral shall not include any of Grantor's rights to the BrE3 and
         Mc3 cell lines to the extent that Grantor has granted a security
         interest to Immunodex, Inc. or its successor covering such cell lines
         solely in connection with that certain license agreement dated as of [
         ], 2005, between Immunodex, Inc. and Somanta Limited:

         a.       All Accounts of Grantor (including, but not limited to, and
                  notwithstanding anything in this Agreement to the contrary,
                  any and all proceeds, money or accounts under all Contracts
                  (without exception);

         b.       All Chattel Paper of Grantor;

         c.       All Contracts of Grantor;

         d.       All Deposit Accounts of Grantor;

         e.       All Documents of Grantor;

         f.       All Equipment of Grantor;

         g.       All Fixtures of Grantor;

                                       3
<PAGE>

         h.       All General Intangibles of Grantor;

         i.       All Instruments of Grantor, including, without limitation,
                  Promissory Notes;

         j.       All Inventory of Grantor;

         k.       All Investment Property of Grantor;

         l.       All Letter-of Credit Rights of Grantor;

         m.       All Supporting Obligations of Grantor;

         n.       All property of Grantor held by Lender, including, without
                  limitation, all property of every description now or hereafter
                  in the possession or custody of or in transit to Lender for
                  any purpose, including, without limitation, safekeeping,
                  collection or pledge, for the account of Grantor, or as to
                  which Grantor may have any right or power;

         o.       All other goods and personal property of Grantor wherever
                  located, whether tangible or intangible, and whether now owned
                  or hereafter acquired, existing, leased or consigned by or to
                  Grantor; and

         p.       To the extent not otherwise included, all Proceeds of each of
                  the foregoing and all accessions to, substitutions and
                  replacements for and rents, profits and products of each of
                  the foregoing.

         If Grantor shall at any time acquire a Commercial Tort Claim, Grantor
         shall promptly notify the Lender in a writing signed by Grantor of the
         brief details thereof and grant to Lender in such writing a security
         interest therein and in the proceeds thereof, all upon the terms of
         this Agreement, with such writing to be in form and substance
         reasonably satisfactory to the Lender.

         Grantor hereby authorizes the Lender to file, without Grantor's
         signature thereon and at Grantor's expense, financing statements,
         continuation statements (including "in lieu" continuation statements)
         and amendments thereto, that describe the Collateral and which contain
         any other information required by Part 5 of Article 9 of the UCC for
         the sufficiency or filing office acceptance of any financing statement,
         continuation statement or amendment, including if Grantor is an
         organization, the type of organization and any organization
         identification number issued to Grantor.

3.       Security for Obligations. This Agreement secures the payment of (i) all
         of the unpaid principal amount of, and accrued interest on (including
         any interest that accrues after the commencement of any bankruptcy
         proceeding) the Note, (ii) the obligation of Grantor to pay any fees,
         costs and expenses of Lender under the Note, and (iii) all other
         obligations, liabilities and indebtedness owed by Grantor to the Lender
         under the Note and the Transaction Documents, in each case, whether now
         existing or hereafter incurred (collectively, the "Obligations").

                                       4
<PAGE>

4.       Rights of Lender; Collection of Accounts.

         a.       Grantor expressly agrees that Grantor shall remain liable
                  under each of its Contracts to observe and perform all the
                  conditions and obligations to be observed and performed by it
                  thereunder and that Grantor shall perform all of its duties
                  and obligations thereunder such that the Grantor shall not be
                  deemed to be in breach of each such Contract. The Lender shall
                  not have any obligation or liability under any Contract by
                  reason of or arising out of this Agreement or the granting to
                  the Lender of a lien therein or the receipt by the Lender of
                  any payment relating to any Contract pursuant hereto, nor
                  shall the Lender be required or obligated in any manner to
                  perform or fulfill any of the obligations of Grantor under or
                  pursuant to any Contract, or to make any payment, or to make
                  any inquiry as to the nature or the sufficiency of any payment
                  received by them or the sufficiency of any performance by any
                  party under any Contract, or to present or file any claim, or
                  to take any action to collect or enforce any performance or
                  the payment of any amounts which may have been assigned to
                  them or to which they may be entitled at any time or times.

         b.       The Lender authorizes Grantor to collect its accounts,
                  provided that such collection is performed in a prudent and
                  businesslike manner, and the Lender may, upon the occurrence
                  and during the continuation of any Event of Default and
                  without notice, limit or terminate said authority at any time.
                  Upon the occurrence and during the continuance of any Event of
                  Default, at the request of the Lender, Grantor shall deliver
                  to Lender all original and other documents which created
                  and/or relate to such accounts, including, without limitation,
                  all original orders, invoices and shipping receipts.

         c.       The Lender may at any time, upon the occurrence and during the
                  continuance of any Event of Default, without notifying Grantor
                  of its intention to do so, notify Account Debtors of Grantor,
                  parties to the Contracts of Grantor, obligors in respect of
                  Instruments of Grantor and obligors in respect of Chattel
                  Paper of Grantor that the Accounts and the right, title and
                  interest of Grantor in, to and under such Contracts,
                  Instruments and Chattel Paper have been assigned to Lender and
                  that payments thereunder or with respect thereto are to be
                  made directly to the Lender. Upon the request of the Lender,
                  Grantor shall promptly so notify such Account Debtors, parties
                  to such Contracts, obligors in respect of such Instruments and
                  obligors in respect of such Chattel Paper. Upon the occurrence
                  and during the continuance of any Event of Default, the Lender
                  may, in Lender's name or in the name of others, communicate
                  with such Account Debtors, parties to such Contracts, obligors
                  in respect of such Instruments and obligors in respect of such
                  Chattel Paper to verify with such parties, to the Lender's
                  satisfaction, the existence, amount and terms of any such
                  Accounts, Contracts, Instruments or Chattel Paper.
                  Notwithstanding the foregoing, Lender shall not notify or
                  otherwise communicate with any parties to Contracts or Account
                  Debtors of Grantor except upon the occurrence of any Event of
                  Default.

                                       5
<PAGE>

         d.       Without limiting the foregoing and Lender's rights as set
                  forth in the foregoing, any action by the Lender pursuant to
                  or as described in Section 4(b) or Section 4(c) hereof shall
                  be in compliance with the provisions set forth in Section
                  12(b)(v) hereof.

5.       Representations and Warranties of Grantor. Grantor represents and
         warrants as follows:

         a.       Grantor is a corporation duly organized, existing and in good
                  standing under the laws of the Delaware, (b) has the legal
                  power to own its property and to carry on its business as now
                  being conducted, and (c) is duly qualified to do business and
                  is in good standing in each jurisdiction in which the
                  character of the properties owned or leased by it therein or
                  in which the transaction of its business makes such
                  qualification necessary, except where the failure to so
                  qualify or be in good standing would not have a Material
                  Adverse Effect;

         b.       Grantor is, and as to Collateral acquired by it from time to
                  time after the date hereof Grantor will be, the owner of all
                  Collateral free from any liens, other than liens created
                  hereby and other than Permitted Liens;

         c.       This Agreement creates, for the benefit and security of Lender
                  in respect of the Obligations, a legally valid and binding
                  lien on, pledge of, and security interest in the Collateral
                  and, upon the filing of a UCC Financing Statement, and any
                  applicable filings with respect to Copyrights, Patents or
                  Trademarks in respect of the Collateral, such lien, pledge and
                  security interest will be perfected and will have priority
                  over the claims of any other present and future creditors of
                  the Company (other than Permitted Liens or liens upon such of
                  the Collateral that must be perfected by possession or control
                  of such Collateral); and

         d.       Grantor's chief executive office, principal place of business
                  and the place where Grantor maintains its records concerning
                  the Collateral are each presently located at the address set
                  forth on the signature page hereof; and Grantor's Federal
                  taxpayer identification number and Grantor's organizational
                  identification number under the laws of the State in which
                  Grantor, as a registered organization, was organized are as
                  set forth on the signature page hereto.

6.       As to the Collateral.

         a.       Notwithstanding anything to the contrary contained herein, the
                  assignment by Grantor herein stated is intended to be an
                  assignment for security purposes and is not intended to divest
                  Grantor of its ownership of the Collateral, except as
                  otherwise provided herein.

         b.       So long as no Event of Default has occurred and is continuing,
                  (i) Grantor shall retain title to and record ownership of the
                  Collateral, and (ii) Grantor shall be entitled to receive any
                  and all income or distributions made with respect to the
                  Collateral, except as provided in Section 6(c) hereof.

                                       6
<PAGE>

         c.       Upon the occurrence and during the continuance of an Event of
                  Default, all income and proceeds of the Collateral which are
                  received by Grantor shall be (i) received in trust for the
                  benefit of the Lender, (ii) segregated from other funds of
                  Grantor, and (iii) forthwith paid over by Grantor to the
                  Lender (for application in accordance with this Agreement) in
                  the same form as so received.

7.       Covenants of Grantor. Grantor covenants and agrees with Lender that
         unless approved by Lender:

         a.       Grantor shall not sell, assign (by operation of law or
                  otherwise), or otherwise transfer any of the Collateral, or
                  attempt or contract to do so, or grant any option with respect
                  to any of the Collateral, except Inventory in the ordinary
                  course of business.

         b.       Other than as expressly set forth in the Share Exchange
                  Agreement (as such term is defined in the Letter Agreement),
                  Grantor shall not change its name, identity or corporate
                  structure in any manner, nor change its jurisdiction of
                  organization, relocate its chief executive office, principal
                  place of business or its principal records with respect to the
                  Collateral, or allow the relocation of any Collateral, in each
                  case without thirty (30) days' prior written notice to the
                  Lender.

         c.       Grantor shall not, directly or indirectly, create or permit to
                  exist any lien upon or with respect to any of the Collateral,
                  and shall defend the Collateral against, and take such other
                  action as is necessary to remove, any lien on the Collateral,
                  except for the lien created hereby and any Permitted Liens.

         d.       Grantor shall maintain all tangible Collateral in good
                  condition and repair, ordinary wear and tear excepted.

         e.       Grantor shall maintain on the Collateral property damage and
                  liability insurance in such amounts, against such risks, and
                  in such forms and with such companies as are customarily
                  maintained by businesses similar to Grantor. Each such policy
                  shall not be materially altered or canceled, and the coverage
                  will not be materially reduced, in any case, without at least
                  thirty (30) days' prior written notice to the Lender. Grantor
                  shall provide the Lender with satisfactory evidence of such
                  insurance coverage at the request of the Lender.

         f.       Grantor shall promptly pay when due all property and other
                  taxes, assessments and government charges or levies imposed
                  upon, and all claims (including claims for labor, materials
                  and supplies) against, the Collateral, except to the extent
                  the validity thereof is being contested in good faith and by
                  appropriate proceedings and adequate reserves are being
                  maintained in connection therewith; provided that this Section
                  7(f) shall not apply to claims for labor, materials or
                  supplies which Payee consents in writing shall be excluded
                  herewith, notwithstanding that such claims, if unpaid, might
                  become a lien or charge upon such properties or any part
                  thereof.

                                       7
<PAGE>

         g.       Grantor shall keep and maintain at its own cost and expense
                  satisfactory and reasonably complete records of the
                  Collateral. Grantor shall furnish the Lender with such
                  information regarding the Collateral as the Lender may
                  reasonably request from time to time and shall allow the
                  Lender, upon reasonable notice, access during normal business
                  hours to inspect the Collateral and Grantor's records,
                  accounts and books pertaining to the Collateral, provided that
                  no restriction as to normal business hours shall be required
                  during the continuance of an Event of Default.

         h.       Grantor shall not knowingly take or omit to take any action,
                  the taking or omission of which might impair Lender's lien on
                  the Collateral or adversely affect the value of the
                  Collateral.

         i.       Upon the occurrence and during the continuance of any Event of
                  Default, Grantor shall not grant any extension of the time of
                  payment of any of its Accounts, Chattel Paper, Instruments or
                  amounts due under any of its Contracts or Documents,
                  compromise, compound or settle the same for less than the full
                  amount thereof, release, wholly or partly, any Person liable
                  for the payment thereof, or allow any credit or discount
                  whatsoever thereon other than trade discounts and rebates
                  granted in the ordinary course of Grantor's business.

         j.       Grantor shall (i) protect, defend and maintain the validity
                  and enforceability of the Copyrights, Patents and Trademarks,
                  (ii) use commercially reasonable efforts to detect
                  infringements of the Copyrights, Patents and Trademarks and
                  promptly advise the Lender in writing of material
                  infringements detected, and (iii) not allow any material
                  Copyrights, Patents or Trademarks to be abandoned, forfeited
                  or dedicated to the public without the written consent of the
                  Lender, unless any such abandonment is appropriate in
                  accordance with reasonable and customary business practice.

         k.       Grantor shall not execute or authorize to be filed in any
                  public office any UCC financing statement (or similar
                  statement or instrument of registration under the law of any
                  jurisdiction) except UCC financing statements filed or to be
                  filed in respect of and covering the lien created by this
                  Agreement.

8.       Further Assurances. Grantor agrees, at any time and from time to time,
         at the expense of Grantor, and upon request of the Lender, to promptly
         execute and deliver all further instruments and documents, and take all
         further action, that may be necessary or desirable, in order to perfect
         and protect any security interest granted or purported to be granted
         hereby or to enable the Lender to exercise and enforce Lender's rights
         and remedies hereunder with respect to any Collateral, including,
         without limitation, (i) delivering and causing to be filed any
         financing or continuation statements (including "in lieu" continuation
         statements) under the UCC with respect to the security interests
         granted hereby, (ii) obtaining "control" by or on behalf of Lender of
         any Investment Property, Deposit Accounts, Letter-of-Credit Rights or
         Electronic Chattel Paper (with reference to applicable provisions of
         the UCC with respect to "control" for such items of Collateral), (iii)
         placing the interest of the Lender as lienholders on the certificate of
         title (or similar evidence of ownership) of any Equipment constituting

                                       8
<PAGE>

         Collateral owned by Grantor which is covered by a certificate of title
         (or similar evidence of ownership), (iv) filing or cooperating with the
         Lender in filing any forms or other documents required to be recorded
         with the United States Patent and Trademark Office, United States
         Copyright Office, or any actions, filings, recordings or registrations
         in any foreign jurisdiction or under any international treaty, required
         to secure or protect Lender's interest in the Collateral, (v)
         transferring Collateral to the possession of the Lender (if a security
         interest in such Collateral can only be perfected by possession), (vi)
         executing and delivering or causing to be delivered written notice to
         insurers of Lender's security interest in, or claim in or under, any
         policy of insurance (including unearned premiums), and (vii) using its
         best efforts to obtain acknowledgements from bailees having possession
         of any Collateral and waivers of liens from landlords and mortgagees of
         any location where any of the Collateral may from time to time be
         stored or located. If Grantor executes and delivers any document or
         instrument pursuant to this Section 8, such document or instrument
         shall be in form and substance reasonably satisfactory to the Lender
         and a copy thereof shall be provided by Grantor to the Lender; and if
         Grantor takes any other action pursuant to this Section 8, such action
         shall be taken with the prior written consent of the Lender and notice
         thereof shall be given by Grantor to the Lender.

9.       Security Interest Absolute. All rights of the Lender and the assignment
         and security interest hereunder, and all obligations of Grantor
         hereunder, shall remain in full force and effect and shall secure the
         Obligations, and shall be absolute and unconditional, irrespective of:

         a.       any change in the time, manner or place of payment of, or in
                  any other term of, all or any of the Obligations or any other
                  amendment or waiver of or any consent to any departure from
                  the Note; or

         b.       any taking, exchange, release or non-perfection of any other
                  collateral, or any release or amendment or waiver of or
                  consent to departure from any guaranty, for all or any of the
                  Obligations; or

         c.       any manner of application of any Collateral, or proceeds
                  thereof, to all or any of the Obligations or any manner of
                  sale or other disposition of any Collateral; or

         d.       any other circumstances other than releases, waivers and the
                  like by the Lender that might otherwise constitute a defense
                  available to, or a discharge of, Grantor's obligations
                  hereunder or Lender's security interest hereunder.

10.      Continuing Security Interest; Sale of Participations; Release of
         Collateral. This Agreement shall create a continuing security interest
         in the Collateral and shall (i) remain in full force and effect until
         the payment in full of the Obligations (subject to Section 14 hereof),
         (ii) be binding upon Grantor, its successors and its permitted assigns
         under the Note, and (iii) inure to the benefit of, and be enforceable
         by (subject to the terms hereof), the Lender and its successors and
         assigns. No sales of participations in, and no other sales,
         assignments, transfers or other dispositions of, any agreement
         governing or instrument evidencing the Obligations or any portion
         thereof or interest therein by the Lender shall in any manner affect

                                       9
<PAGE>

         the lien granted to the Lender hereunder. Subject to Section 14 hereof,
         upon the payment in full of the Obligations, the security interest
         granted hereby shall terminate and all rights to the Collateral shall
         revert to Grantor. Upon any such termination, the Lender will, at
         Grantor' expense, execute and deliver to Grantor such documents as
         Grantor shall reasonably request to evidence such termination. The
         Lender shall, at the request of Grantor, deliver any document
         reasonably necessary to release any lien granted hereunder with respect
         to any Collateral Grantor is transferring.

11.      Lender's Duties. The powers conferred on the Lender hereunder are
         solely to protect Lender's interest in the Collateral as a secured
         party and shall not impose any duty upon the Lender to exercise any
         such powers. Except for the safe custody of any Collateral in Lender's
         possession and the accounting for money actually received by Lender
         hereunder, the Lender shall not have any duty as to any Collateral or
         as to the taking of any necessary steps to preserve any rights
         pertaining to any Collateral. The Lender shall not have any
         responsibility or liability for the collection of any proceeds of any
         Collateral or by reason of any invalidity, lack of value or
         uncollectability of any of the Collateral. The Lender shall be deemed
         to have exercised reasonable care in the custody and preservation of
         any Collateral in the Lender's possession if such Collateral is
         accorded treatment substantially equal to that which the Lender accords
         its own property.

12.      Events of Default; Remedies Upon Default; Actions by Lender.

         a.       The occurrence of an Event of Default under and as defined in
                  the Note shall constitute an "Event of Default" hereunder.

         b.       If any Event of Default shall have occurred:

                  i.       The Lender may exercise in respect of the Collateral,
                           in addition to other rights and remedies provided for
                           herein or otherwise available to Lender (or any of
                           them), all the rights and remedies of a secured party
                           on default under the UCC (whether or not the UCC
                           applies to the affected Collateral), and may also,
                           without notice of any kind or demand of performance
                           or other demand (all and each of which demands and
                           notices are hereby expressly waived to the maximum
                           extent provided by the UCC and other applicable law)
                           reclaim, take possession, recover, store, maintain,
                           finish, repair, prepare for sale or lease, advertise
                           for sale or lease and sell the Collateral or any part
                           thereof in one or more parcels at public or private
                           sale, at any exchange, broker's board or at the
                           Lender's offices or elsewhere, for cash, on credit,
                           or for future delivery, and upon such other terms as
                           the Lender may deem commercially reasonable. In
                           connection with the liquidation, sale or other
                           disposition of the Collateral, the Lender is granted
                           a non-exclusive, royalty-free license or other right
                           to use, without charge, Grantor' labels, patents,
                           copyrights, trade secrets, trade names, trademarks,
                           service marks, or any similar property as it pertains
                           to the Collateral, in completing a liquidation, sale
                           or other disposition of the Collateral. The Lender
                           shall not be obligated to make any sale of Collateral

                                       10
<PAGE>

                           regardless of notice of sale having been given. The
                           Lender may adjourn any public or private sale from
                           time to time by announcement at the time and place
                           fixed therefor, and such sale may, without further
                           notice, be made at the time and place to which it was
                           so adjourned. Grantor agrees that in any sale of any
                           of the Collateral, whether at a foreclosure sale or
                           otherwise, the Lender is hereby authorized to comply
                           with any limitation or restriction in connection with
                           such sale as it may be advised by counsel is
                           necessary in order to avoid any violation of
                           applicable law (including compliance with such
                           procedures as may restrict the number of prospective
                           bidders and the Lender, require that such prospective
                           bidders and the Lender have certain qualifications
                           and restrict such prospective bidders and the Lender
                           to Persons who will represent and agree that they are
                           purchasing for their own account for investment and
                           not with a view to the distribution or resale of such
                           Collateral), and Grantor further agrees that such
                           compliance shall not result in such sale being
                           considered or deemed not to have been made in a
                           commercially reasonable manner, nor shall the Lender
                           be liable or accountable to Grantor for any discount
                           allowed by reason of the fact that such Collateral is
                           sold in compliance with any such limitation or
                           restriction.

                  ii.      Grantor authorizes the Lender, on the terms set forth
                           herein, to enter the premises where the Collateral
                           (or any part of it) is located, to take possession of
                           the Collateral (or any part of it), and to pay,
                           purchase, contract, or compromise any encumbrance,
                           charge or lien which, in the opinion of the Lender,
                           appears to be prior or superior to its security
                           interest. Grantor further agrees, at the Lender's
                           request, to assemble the Collateral and make it
                           available to the Lender at places which the Lender
                           shall reasonably select. To the maximum extent
                           permitted by applicable law, Grantor hereby waives
                           all claims, damages, and demands against the Lender
                           arising out of the repossession, retention or sale of
                           the Collateral.

                  iii.     The Lender may sell Collateral without giving
                           warranties as to such Collateral. The Lender may
                           specifically disclaim any warranties of title or the
                           like. The foregoing will not be considered adversely
                           to affect the commercial reasonableness of any sale
                           of Collateral.

                  iv.      If the Lender sells any of the Collateral upon
                           credit, Grantor will be credited only with, and at
                           the time of, payments actually made by the purchaser
                           in such sale received by the purchaser and applied to
                           the indebtedness of such purchaser. In the event the
                           purchaser in such sale fails to pay for the
                           Collateral, the Lender may resell the Collateral and
                           Grantor shall be credited with the proceeds of the
                           resale in accordance with the preceding sentence. In
                           the event the Lender purchases any of the Collateral
                           being sold, the Lender may pay for the Collateral by
                           crediting some or all of the amounts described in
                           clauses first and second of Section 12(b)(v) hereof.

                                       11
<PAGE>

                  v.       Any cash held by the Lender as Collateral and all
                           cash proceeds received by the Lender in respect of
                           any sale of, collection from, or other realization
                           upon, all or any part of the Collateral or the
                           exercise of any other remedies consequent upon an
                           Event of Default shall be applied in whole or in part
                           by the Lender against all or any part of the
                           Obligations in the following order:

                           First, to the Lender in an amount sufficient to pay
                           in full the Obligations, including all reasonable
                           fees, costs, expenses, liabilities and advances
                           incurred or made by the Lender in connection with the
                           sale, disposition or other realization of the
                           Collateral, including without limitation, reasonable
                           attorneys' fees;

                           Second, upon payment in full of all the Obligations,
                           to Grantor or to whomsoever may be lawfully entitled
                           to receive such surplus.

                  vi.      Grantor shall remain liable for any deficiency if the
                           proceeds of any sale or disposition of the Collateral
                           are insufficient to fully pay the Obligations, and
                           Grantor also shall be liable for the reasonable costs
                           and expenses (including reasonable attorneys' fees
                           and expenses) incurred by Lender to collect such
                           deficiency.

                  vii.     Grantor hereby waives presentment, demand, protest or
                           any notice (to the maximum extent permitted by
                           applicable law) of any kind in connection with this
                           Agreement or any Collateral.

13.      Expenses. Grantor shall upon demand pay to the Lender the amount of any
         and all reasonable expenses, including the reasonable and necessary
         fees and expenses the Lender's counsel and of any experts and agents,
         which the Lender may incur in connection with (a) the administration of
         this Agreement, (b) the custody or preservation of, or the sale of,
         collection from, or other realization upon, any of the Collateral, (c)
         the exercise or enforcement of any of the rights of the Lender
         hereunder, or (d) the failure by Grantor to perform or observe any of
         the provisions hereof or of under the Note.

14.      Reinstatement. This Agreement shall remain in full force and effect and
         continue to be effective should any petition be filed by or against
         Grantor for liquidation or reorganization, should Grantor become
         insolvent or make an assignment for the benefit of creditors or should
         a receiver or trustee be appointed for all or any significant part of
         Grantor's property and assets, and shall continue to be effective or be
         reinstated, as the case may be, if at any time payment and performance
         of the Obligations, or any part thereof, is, pursuant to applicable
         law, rescinded or reduced in amount, or must otherwise be restored or
         returned by any obligee of the Obligations, whether as a "voidable
         preference," "fraudulent conveyance," or otherwise, all as though such
         payment or performance had not been made. In the event that any
         payment, or any part thereof, is rescinded, reduced, restored or
         returned, the Obligations shall be reinstated and deemed reduced only
         by such amount paid and not so rescinded, reduced, restored or
         returned.

                                       12
<PAGE>

15.      Amendments, Etc. No amendment or waiver of any provision of this
         Agreement, nor consent to any departure by Grantor herefrom, shall in
         any event be effective unless the same shall be in writing and signed
         by the parties necessary to amend the Note, and then such waiver or
         consent shall be effective only in the specific instance and for the
         specific purpose for which given.

16.      Cumulative Remedies. The rights and remedies hereunder provided are
         cumulative and may be exercised singly or concurrently, and are not
         exclusive of any rights and remedies provided by law. The Lender shall
         not by any act, delay, omission or otherwise be deemed to have waived
         any of their respective rights or remedies hereunder, nor shall any
         single or partial exercise of any right or remedy hereunder on any one
         occasion preclude the further exercise thereof or the exercise of any
         other right or remedy.

17.      Lender May Perform; Reimbursement; Power of Attorney.

         a.       If Grantor fails to perform any obligation of Grantor under
                  this Agreement, the Lender may, but shall not have the
                  obligation to, without prior notice to or obtaining the
                  consent of Grantor, perform that obligation on behalf of
                  Grantor, including, without limitation, obtaining insurance
                  coverage for the Collateral and satisfying tax obligations or
                  liens on the Collateral. Grantor shall reimburse the Lender on
                  demand for all reasonable expenses and reasonable attorneys'
                  fees incurred by the Lender in performing any such obligation,
                  including interest at the interest rate specified in the Note.

         b.       Grantor hereby absolutely and irrevocably constitutes and
                  appoints the Lender as Grantor's true and lawful agent and
                  attorney-in-fact, with full power of substitution, in the name
                  of Grantor: (a) to take any and all such action as the Lender
                  or any of its agents, nominees or attorneys may, in its or
                  their sole and absolute discretion, reasonably determine as
                  necessary or advisable for the purpose of maintaining,
                  preserving or protecting the security constituted by this
                  Agreement or any of the rights, remedies, powers or privileges
                  of the Lender under this Agreement; and (b) generally, in the
                  name of Grantor to exercise all or any of the powers,
                  authorities and discretions, conferred on or reserved to the
                  Lender by or pursuant to this Agreement, and (without
                  prejudice to the generality of any of the foregoing) to seal
                  and deliver or otherwise perfect any deed, assurance,
                  agreement, instrument or act as the Lender may deem proper in
                  or for the purpose of exercising any of such powers,
                  authorities or discretions, in each case. Grantor hereby
                  ratifies and confirms, and hereby agrees to ratify and
                  confirm, whatever lawful acts the Lender or any of its agents,
                  nominees or attorneys shall do or purport to do in the
                  exercise of the power of attorney granted to the Lender
                  pursuant to this Section 17(b), which power of attorney, being
                  given for security, is irrevocable. Notwithstanding anything
                  to the contrary in this Section 17(b), no such action as
                  Grantor's true and lawful agent and attorney-in-fact may be
                  taken by Lender except upon the occurrence of any Event of
                  Default.

18.      Addresses for Notices. All notices and other communications to any
         party provided for hereunder shall be in writing and mailed by
         registered or certified mail, return receipt requested, to the

                                       13
<PAGE>

         addresses for the Grantor and the Lender set forth on the signature
         pages hereto, or, as to any party, to such other address as shall be
         designated by such party in a written notice to each other party
         complying as to delivery with the terms of this Section 18. A copy of
         each notice to Grantor shall also be sent to Foley & Lardner LLP, 402
         W. Broadway, 23rd Floor, San Diego, CA 92101, Attn: Kenneth D. Polin,
         Esq. A copy of each notice to Lender shall also be sent to Wiggin and
         Dana LLP, 450 Lexington Avenue, Suite 3800, New York, NY 10017,
         Attention: Christopher P. Giordano, Esq. All such notices and other
         communications shall be effective (i) upon personal delivery to the
         party to be notified; (ii) on the date of first attempted delivery
         after having been sent by registered or certified mail, return receipt
         requested, postage prepaid; (iii) one (1) day after deposit with a
         nationally recognized overnight courier, specifying next day delivery,
         with written verification of receipt.

19.      Forbearance; Delay. Any forbearance, failure or delay by the Lender in
         exercising any right, power or remedy hereunder shall not preclude the
         exercise thereof. Every right, power or remedy of the Lender shall
         continue in full force and effect until such right, power or remedy is
         specifically waived by an instrument in writing executed by the Lender.

20.      Severability. Any provision of this Agreement which is prohibited or
         unenforceable in any jurisdiction shall, as to such jurisdiction, be
         ineffective to the extent of such prohibition or unenforceability
         without invalidating the remaining provisions hereof, and any such
         prohibition or unenforceability in any jurisdiction shall not
         invalidate or render unenforceable such provision in any other
         jurisdiction.

21.      Successors and Assigns. This Agreement is for the benefit of the Lender
         and its successors and assigns, and in the event of an assignment of
         all or any of the Obligations, the rights hereunder, to the extent
         applicable to the indebtedness so assigned, may be transferred with
         such indebtedness. This Agreement shall be binding on the Grantor and
         its respective successors and assigns.

22.      Consent To Jurisdiction And Service Of Process. ANY LEGAL ACTION OR
         PROCEEDING WITH RESPECT TO THIS AGREEMENT MAY BE BROUGHT IN THE COURTS
         OF THE STATE OF NEW YORK OR OF THE UNITED STATES FOR THE SOUTHERN
         DISTRICT OF NEW YORK, AND BY EXECUTION AND DELIVERY OF THIS AGREEMENT,
         EACH OF GRANTOR AND LENDER CONSENTS, FOR ITSELF AND IN RESPECT OF ITS
         PROPERTY, TO THE NON-EXCLUSIVE JURISDICTION OF THOSE COURTS. EACH OF
         THE GRANTOR AND LENDER IRREVOCABLY WAIVES ANY OBJECTION, INCLUDING ANY
         OBJECTION TO THE LAYING OF VENUE OR BASED ON THE GROUNDS OF FORUM NON
         CONVENIENS, WHICH IT MAY NOW OR HEREAFTER HAVE TO THE BRINGING OF ANY
         ACTION OR PROCEEDING IN SUCH JURISDICTION IN RESPECT OF THIS AGREEMENT
         OR ANY DOCUMENT RELATED HERETO. EACH OF GRANTOR AND LENDER WAIVES
         PERSONAL SERVICE OF ANY SUMMONS, COMPLAINT OR OTHER PROCESS, WHICH MAY
         BE MADE BY ANY OTHER MEANS PERMITTED BY NEW YORK LAW.

                                       14
<PAGE>

23.      Waiver Of Jury Trial. EACH OF GRANTOR AND LENDER WAIVES ITS RIGHT TO A
         TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT
         OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
         HEREBY, IN ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE
         BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, WHETHER WITH RESPECT TO
         CONTRACT CLAIMS, TORT CLAIMS, OR OTHERWISE. EACH OF GRANTOR AND LENDER
         AGREES THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE TRIED BY A COURT
         TRIAL WITHOUT A JURY. WITHOUT LIMITING THE FOREGOING, EACH OF GRANTOR
         AND LENDER FURTHER AGREES THAT ITS RIGHT TO A TRIAL BY JURY IS WAIVED
         BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM OR OTHER
         PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY
         OR ENFORCEABILITY OF THIS AGREEMENT OR ANY PROVISION HEREOF. THIS
         WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS
         OR MODIFICATIONS TO THIS AGREEMENT.

24.      Advice of Counsel; Construction. Each of Grantor and Lender represents
         and warrants that it has discussed this Agreement, including, without
         limitation, Section 22 and Section 23 hereof, with its counsel. The
         parties hereto have participated jointly in the negotiation and
         drafting of this Agreement. In the event an ambiguity or question of
         intent or interpretation arises, this Agreement shall be construed as
         if drafted jointly by the parties hereto and no presumption or burden
         of proof shall arise favoring or disfavoring any party by virtue of the
         authorship of any provisions of the Agreement.

25.      Headings. The various headings in this Agreement are inserted for
         convenience only and shall not affect the meanings or interpretation of
         this Agreement or any provision hereof.

26.      Governing Law. This Agreement shall be governed by, and construed in
         accordance with, the internal laws of the State of New York determined
         without reference to principles of conflicts of law, except to the
         extent that the validity or perfection of any security interest created
         hereunder, or remedies hereunder, in respect of any item of the
         Collateral is governed by the laws of a jurisdiction other than the
         State of New York.

27.      Counterparts; Facsimile Execution. This Agreement may be executed in
         counterparts, each of which shall constitute an original. A facsimile
         or other copy of any signature hereto transmitted by electronic means
         shall have the same force and effect as an original thereof.

                            [signature page follows]

                                       15
<PAGE>

         IN WITNESS WHEREOF, the parties have caused this Agreement to be duly
executed and delivered as of the date first above written.

                                      BRIDGE ONCOLOGY PRODUCTS, INC.

                                      By: /s/ TERRANCE J. BRUGGEMAN
                                          --------------------------------------
                                          Name:  Terrance J. Bruggeman
                                          Title: Chairman

                                          Address: 10 Old Course Drive
                                                   Newport Beach, CA 92660
                                                   Attention: Terrance Bruggeman

                                          Telephone No.: 949-706-3697
                                          Federal Taxpayer Identification
                                             No.: 20-2673926
                                          Organizational No.:
                                          State of Incorporation:  Delaware

                                      SCO CAPITAL PARTNERS LLC

                                      By: /s/ STEVEN ROUHANDEH
                                          --------------------------------------
                                          Name:  Steven Rouhandeh
                                          Title: Chairman

                                          Address: 1285 Avenue of the Americas
                                                   35th Floor
                                                   New York, New York  10019
                                          Telephone Number: 212-554-4158

                                       16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]